Bettany (300957): Revenue growth in 23 years, performance under pressure for 24 years, looking forward to an improvement in business quality
Revenue and net profit attributable to mother in '23 were +10%, -28% YoY, 24Q1 +27%, +12%. Bettany published the 2023 Annual Report and the 2024 Quarterly Report. The company achieved operating income in 202355
Dongwu Securities released a research report on April 26 stating that it gave Bethany (300957.SZ) a purchase rating. The main reasons for the rating include: 1) the performance was pressured by 23 years, and growth resumed in 24Q1; 2) Winona's head effect
Dongwu Securities released a research report on April 26 stating that it gave Bethany (300957.SZ) a purchase rating. The main reasons for the rating include: 1) the performance was pressured by 23 years, and growth resumed in 24Q1; 2) Winona's head effect was remarkable, and the makeup growth rate was beautiful; 3) offline self-management maintained a high growth rate, and the number of stores opened continued to grow; 4) the cost ratio was optimized during the 24Q1 period. (Mainichi Keizai Shimbun)
Bethany (300957) Company Information Update Report: 2024Q1 Operation Regeneration Sensitive Skin Leading Company Enters a New 2.0 Era
Incident: Profit side under pressure in 2023, 2024Q1 operations picked up overall, and the company released an annual report and a quarterly report: achieved revenue of 5.522 billion yuan (+10.1%) and net profit to mother of 757 million yuan (-2) in 2023
Bettany (300957): 2023 results bottomed out, 24Q1 improved month-on-month
Guide to this report: The company's performance in 2023 fell short of expectations, mainly due to sales falling short of expectations during the Double Eleven promotion, which raised the cost rate. 24Q1 revenue and profit improved significantly by +27% and +22%, respectively, and we look forward to continued recovery in the future.
Bethany (300957): Expected to go to battle lightly in '24
23Q4 performance is under phased pressure. 24Q1 revenue and profit have improved markedly, with 23 year revenue of 5.522 billion yuan/yoy 10.14%, and net profit of 757 million yuan/yoy -28.02%. 23Q
Bettany (300957): First-quarter revenue increased 27% year-on-year, positive adjustments drive a gradual recovery in performance
As a leading domestic skincare leader, Bethany's profit in 2023 is under pressure due to multiple factors. The company achieved revenue of 5,522 million/yoy +10.14% in 2023; net profit to mother of 757 million/yoy-28.02
Bettany (300957): Deducting non-net profit in 1Q24 and increasing 22%. Employee stock ownership plans show confidence in development
The 2023 results fell short of our expectations, and the 1Q24 results were in line with our expectations, and Bethany announced 2023 and 1Q24 results: 2023 revenue of $5.522 billion, +10.1% YoY; net profit to mother 7.
Bethany: Strong revenue growth in 2023 to 5.52 billion yuan 2024Q1 revenue increased 27.1% year-on-year, and sub-brands actively strengthened
Glonghui, April 26 | Bethany (300957.SZ), the first stock of effective skincare, continued to grow strongly, with revenue of 5.52 billion yuan in 2023, and the year-on-year increase accelerated to 27.1% in the first quarter of 2024. Sub-brand rookies are gaining strength and positive returns on offline investment, and new opportunities are yet to be developed in the popular beauty care market.
Betany (300957.SZ) announced first-quarter results. Net profit of 177 million yuan increased 11.74% year-on-year
Betany (300957.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 10...
Bethany (300957): Expanding sensitive boundaries and looking forward to the Winona 2.0 era
Incident Overview The company released its 2023 report and 2024 quarterly report. In 2023, the company achieved revenue of 5.522 billion yuan, +10.14% year on year; net profit attributable to mother was 757 million yuan, -28.02% year on year; net without return to mother
Bettany (300957): Marginal improvement in Q1 performance, outstanding offline revenue contribution
Event: The company released its 2023 & 2024 Q1 results report. 1) Achieved revenue of 5.52 billion yuan in 2023, +10.1% year-on-year; realized net profit of 760 million yuan, or -28.0% year-on-year, actual
Express News | Bethany's strong revenue growth in 2023 was extended to 27.1% in Q1 2024
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutica
Medical beauty stocks fell collectively. Among them, Jiangsu Wuzhong fell to a standstill, Aimeike fell more than 9%, Jingfeng Pharmaceutical fell more than 5%, Huadong Pharmaceutical, Betaini, and Guanhao Biotech fell more than 4%, and Teyi Pharmaceutical, Shuyu Pingmin, Changshan Pharmaceutical, and Dian Diagnosis fell more than 3%.
Express News | Today, a total of 21 companies lifted the ban on restricted shares. The market value of Bethany lifted the ban exceeded 10 billion dollars
Express News | A total of 58 companies lifted the ban on restricted shares this week, with Bethany, Suneng shares, and Chu Tianlong having the highest market capitalization
Cinda Securities: Steady growth in large domestic sunscreen products, focus on leading cosmetics companies with alpha opportunities
Advances in technology of domestic brands and accurate grasping of consumer trends will help domestic sunscreen products occupy more market share.
Bethany (300957): Embarking on a New Journey
Winona 2.0 era begins. Looking forward to new changes in 2024, Winona is expected to enter a new era of 2.0 skin health: further deepening basic research and further expansion of efficacy research, from soothing and repairing to advanced sensitive skin PLUS, for dry and itchy skin
Bethany (300957): Winona 2.0 starts, performance improvements can be expected
Guide to this report: The company's main brand, Winona, underwent a 2.0 strategic upgrade to expand Sensitive Skin Plus and open up room for brand improvement. Recently, the upgraded version of Special Cream 2.0 was launched, which combined with the optimization of the company's organizational team, which is expected to drive performance improvement. throws
Bethany (300957.) : From “focus” to “specialized research”, entering a new era of skin health
The incident describes the company recently held a press conference on the Winona 2.0 strategic upgrade. This article aims to sort out the company's strategy and core product upgrades. The incident review went from “focus” to “specialized research”, when Winona's brand strategy was upgraded and fully entered 2.0
Bethany Guo Zhenyu: Research centers will be established in Japan and Switzerland this year
Glonghui March 4 | Bethany's Winona brand upgrade conference was held on March 1. At the event, Chairman Guo Zhenyu revealed that the company has established a French research center in 2023. This year, it will establish research centers in Japan and Switzerland to focus on formulations and anti-aging. The future layout of optoelectronic research centers is beginning to take shape.
No Data